Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Co-Diagnostics, Inc. - Common Stock
(NQ:
CODX
)
0.4600
-0.0082 (-1.75%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Co-Diagnostics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
CODX FINAL DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important October 17 Deadline in Securities Class Action - CODX
October 05, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MINISO, Co-Dx, Ampio, and Sinovac and Encourages Investors to Contact the Firm
October 02, 2022
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODX
October 02, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
September 27, 2022
Via
Benzinga
7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’
September 27, 2022
Investors have seven widely-followed vaccine stocks to sell now, after the world decided the pandemic is over.
Via
InvestorPlace
CODX NOTICE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODX
September 26, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
September 23, 2022
The World Health Organization (WHO) warned that it struggles to identify and
Via
Benzinga
CODX INVESTOR NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODX
September 21, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
ROSEN, A TOP RANKED LAW FIRM, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODX
September 10, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Co-Diagnostics's Return On Capital Employed Overview
September 07, 2022
Benzinga Pro data, Co-Diagnostics (NASDAQ:CODX) reported Q2 sales of $5.02 million. Earnings fell to a loss of $2.69 million, resulting in a 122.93% decrease from last quarter.
Via
Benzinga
ROSEN, LEADING INVESTOR COUNSEL, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODX
September 05, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Co-Diagnostics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – CODX
August 29, 2022
From
The Rosen Law Firm, P.A.
Via
Business Wire
NASDAQ:CODX Shareholder Notice: Lawsuit Alleges Securities Laws Violations by Co-Diagnostics, Inc.
August 29, 2022
San Diego, CA -- (SBWIRE) -- 08/29/2022 -- An investor, who purchased NASDAQ:CODX shares filed a lawsuit against Co-Diagnostics, Inc. over alleged violations of Federal Securities Laws..
Via
SBWire
No More Free COVID-19 At-Home Tests, Federal Government Says
August 29, 2022
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au
Via
Benzinga
ROSEN, LEADING INVESTOR COUNSEL, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODX
August 27, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Co-Diagnostics, Inc. (CODX) Investors of Class Action and to Actively Participate
August 26, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
ROSEN, A LONGSTANDING LAW FIRM, Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CODX
August 24, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
CODX Stock News: Robbins LLP is Investigating Co-Diagnostics, Inc. (CODX) on Behalf of Shareholders
August 24, 2022
From
Robbins LLP
Via
Business Wire
CODX Shareholder Notice: Robbins LLP Reminds Investors of Class Action Against Co-Diagnostics, Inc. (CODX)
August 19, 2022
From
Robbins LLP
Via
Business Wire
CO-DX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Co-Diagnostics, Inc. and Encourages Investors to Contact the Firm
August 17, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Stocks That Hit 52-Week Lows On Thursday
August 18, 2022
During Thursday's trading, 62 companies set new 52-week lows.
Via
Benzinga
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Co-Diagnostics, Inc. (CODX)
August 17, 2022
From
Robbins LLP
Via
Business Wire
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Co-Diagnostics, Inc. with Losses of $100,000 to Contact the Firm
August 17, 2022
From
The Schall Law Firm
Via
Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Co-Diagnostics, Inc. with Losses of $100,000 to Contact the Firm
August 16, 2022
From
The Schall Law Firm
Via
Business Wire
EQUITY ALERT: Rosen Law Firm Encourages Co-Diagnostics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CODX
August 16, 2022
From
Rosen Law Firm
Via
Business Wire
Mizuho Increases PT On ON Semiconductor, Charter Communications Price Target Cut By 37%
August 15, 2022
Atlantic Equities lowered the price target on Charter Communications, Inc. (NASDAQ: CHTR) from $755 to $477. Charter Communications shares fell 1.7% to $470.00 in pre-market trading.
Via
Benzinga
This Analyst Boosts Price Target On Dillard's; Also Check Out Some Other Big PT Changes
August 15, 2022
JP Morgan raised the price target for Dillard's, Inc. (NYSE: DDS) from $210 to $298. Dillard's shares rose 0.9% to $304.42 in pre-market trading.
Via
Benzinga
Illumina, Poshmark, Olo And Some Other Big Losers From Friday
August 15, 2022
U.S. stocks closed higher on Friday, with the Dow Jones gaining more than 400 points. Here is the list of some big stocks moving lower in the previous session.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
August 12, 2022
Via
Benzinga
Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday
August 15, 2022
Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.